-
New trial engineers immune cells to treat solid tumors
-
New immunotherapy trial for HPV-associated cancers
-
New clinical trial uses targeted cancer drug for lymphatic system disease
-
New trial evaluates investigational drug for endometrial and breast cancers
-
Selumetinib granted orphan status for NF1 treatment
-
Application process is open! Lasker #clinicalresearch Scholar positions available. Learn more about the program and… https://t.co/xdcF9KIXwY
-
Congratulations to Andrea Gross, M.D., from our Pediatric Oncology Branch on receiving the @ASCO Bradley Stuart Bel… https://t.co/BKa22eVPlD
-
Congratulations to Jack Shern, M.D., from our Pediatric Oncology Branch for receiving the James B. Nachman Endowed… https://t.co/uSz5L3GF2b
-
Researchers are engineering immune cells to provide highly personalized treatments for common cancers… https://t.co/fZJ4jT8Ep7
-
RT @NCICRCHD: In honor of #BrainTumorAwarenessMonth, @theNCI is hosting a Facebook Live on 5/25 at 11:00am ET on #braintumor rese… https://t.co/0ukiggUCQh
-
Investments in #basicresearch deepen our understanding of cancer and lead to new interventions, like… https://t.co/QH9Jb54yZQ
-
#BladderCancerAwarenessMonth search for #clinicaltrials on our website at: https://t.co/gJEAx96An4. If you need mor… https://t.co/RZfWxfSDbx
